Previse

Baltimore, United States

Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.

$1.8M raised

Oct 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Previse raised?

Previse has raised $1.8M in total funding. The most recent round was Grant. The last funding was announced in October 2024.

Who are Previse's investors?

Previse's investors include Gaingels, TEDCO, National Cancer Institute, Wexford Science & Technology, Riptide Ventures.

Where is Previse headquartered?

Previse is headquartered in Baltimore, United States.

What does Previse do?

Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.

What stage is Previse at?

Previse is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 22, 2024.

MLA

"Previse — Funding & Investors." VCBacked, October 22, 2024, https://www.vcbacked.co/company/previse. Accessed July 1, 2026.

APA

VCBacked. (2024). Previse — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/previse

Wikipedia (cite web)

{{cite web |title=Previse — Funding & Investors |url=https://www.vcbacked.co/company/previse |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 22, 2024.